19-Apr-2024
Jack Daniels Parent Company, EA, Cognizant Among 6 Stocks That Shine When Nvidia Slips: Analysis
Benzinga (Fri, 19-Apr 5:31 AM ET)
Henry Schein Supports The 'Carry The Load' Memorial May Campaign For Third Consecutive Year
Business Wire (Thu, 18-Apr 6:30 AM ET)
Henry Schein to Webcast First Quarter 2024 Conference Call on Tuesday, May 7, 2024 at 10:00 A.M. ET
Business Wire (Thu, 11-Apr 6:30 AM ET)
Business Wire (Wed, 10-Apr 4:05 PM ET)
Henry Schein Completes Acquisition of Majority Interest of TriMed, Inc.
Business Wire (Thu, 4-Apr 6:30 AM ET)
Viome Is Partnering with Henry Schein to Provide Better Access to Oral Health Pro With CancerDetect
PRNewswire (Tue, 2-Apr 10:14 AM ET)
Henry Schein Presents THRIVELIVE 2024
Business Wire (Tue, 2-Apr 8:01 AM ET)
Business Wire (Mon, 4-Mar 6:30 AM ET)
Business Wire (Tue, 27-Feb 6:00 AM ET)
Nominations Now Open for Henry Schein Medical's Athletics and Schools 2024 Rising Star Award
Business Wire (Thu, 22-Feb 6:30 AM ET)
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. The company operates in two reportable segments; health care distribution and technology & value-added services. The healthcare distribution segment is engaged in combining global dental and medical businesses and distributes consumable products, small equipment, laboratory products, and Vitamins. The technology and value-added services reportable segment provides software, technology & other value-added services to health care practitioners. The majority of revenue is derived from the health care distribution segment.
Henry Schein trades on the NASDAQ stock market under the symbol HSIC.
As of April 19, 2024, HSIC stock price climbed to $70.86 with 706,368 million shares trading.
HSIC has a beta of 0.47, meaning it tends to be less sensitive to market movements. HSIC has a correlation of 0.08 to the broad based SPY ETF.
HSIC has a market cap of $9.21 billion. This is considered a Mid Cap stock.
Last quarter Henry Schein reported $3 billion in Revenue and $.66 earnings per share. This fell short of revenue expectation by $-23 million and missed earnings estimates by -$.04.
In the last 3 years, HSIC stock traded as high as $92.68 and as low as $60.01.
The top ETF exchange traded funds that HSIC belongs to (by Net Assets): VTI, VB, VOO, VBR, SPY.
HSIC has underperformed the market in the last year with a return of -14.6%, while the SPY ETF gained +21.2%. In the last 3 month period, HSIC fell short of the market, returning -4.3%, while SPY returned +3.0%. However, in the most recent 2 weeks HSIC has outperformed the stock market by returning -2.3%, while SPY returned -4.5%.
HSIC support price is $69.05 and resistance is $70.89 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HSIC stock will trade within this expected range on the day.